Furthermore, the disease-free survival probability and progress-free survival were also analyzed by the UCSC Xena tool, which showed that lower FTO expression levels were correlated with a worse survival probability in PCa patients (P < 0.01) (Fig. 1H, I). This evidence concerns the gene FTO and posterior cortical atrophy.